Feldan Therapeutics
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Seed | ||
$13.8m | Series A | ||
* | N/A | Grant | |
* | $16.5m | Series B | |
* | $21.0m | Series B | |
Total Funding | CAD70.0m |
Related Content
Recent News about Feldan Therapeutics
EditFeldan Therapeutics is a biopharmaceutical company focused on developing breakthrough treatments that work within cells. The company operates in the healthcare and biotechnology market, targeting medical professionals and institutions that require advanced therapeutic solutions. Feldan's core product is the Feldan Shuttle, a unique peptide-based technology that allows for the intracellular delivery of therapeutics, reaching targets that existing drugs cannot. This innovative approach aims to improve the quality of life by addressing unmet medical needs. Feldan generates revenue through the development and commercialization of its proprietary technologies and therapeutic solutions, partnering with other biotech firms and healthcare providers to bring its products to market.
Keywords: biopharmaceutical, intracellular, therapeutics, peptide-based, Feldan Shuttle, healthcare, biotechnology, medical professionals, advanced solutions, proprietary technologies.